American Heart Association http://www.heart.org
US Food and Drug Administration http://www.fda.gov
Health Canada http://www.hc-sc.gc.ca
Heart and Stroke Foundation of Canada http://www.heartandstroke.com
Amarenco P, Bogousslavsky J, et al. High-dose atorvastatin after stroke or transient ischemic attack.
N Engl J Med. 2006;355:549-559.
Grundy SM, Cleeman JL, et al. National Heart, Lung, and Blood Institute, American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines.
Lemaitre RN, Psaty B, et al. Therapy with hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults.
Arch Intern Med. 2002;162:1395-1400.
Lipid-lowering pharmacotherapy overview. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated September 12, 2014. Accessed December 11, 2014.
Middleton A, Binbrek AS, et al. Achieving 2003 European lipid goals with rosuvastatin and comparator statins in 6,743 patients in real-life clinical practice: DISCOVERY meta-analysis.
Curr Med Res Opin. 2006;22: 1181-1191.
Statins. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated November 4, 2014. Accessed December 11, 2014.
Statins. Food and Drug Administration website. Available at: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm294358.htm. Updated November 21, 2012. Accessed December 11, 2014.
Statin drugs. EBSCO Natural and Alternative Treatments website. Available at: http://www.ebscohost.com/biomedical-libraries/natural-alternative-treatments. Updated September 18, 2014. Accessed December 11, 2014.
Statins for prevention of cardiovascular disease. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated September 15, 2014. Accessed December 11, 2014.
Stender S, Schuster H, et al. Comparison of rosuvastatin with atorvastatin, simvastatin, and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Diabetes Obes Metab.
Tahara N, Kai H, et al. Simvastatin attenuates plaque inflammation: evaluation by fuorodeoxyglucose positron emission tomography.
J Am Coll Cardiol. 2006;48:1825-1831.
1/30/2009 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Mills EJ, Rachlis B, et al. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
J Am Coll Cardiol.
3/6/2012 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: FDA announces safety changes in labeling for some cholesterol-lowering drugs. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm293623.htm. Updated March 2, 2012. Accessed December 11, 2014.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
It's time to stop guessing. If you want to make some changes but just aren't sure how, the free personal health survey from LiveWell is a great place to start.
Fight heart disease and prevent heart attacks. HeartSHAPE® is a painless, non-invasive test that checks pictures of your heart for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.